Full-Time

Senior Manager

Field Medical Analytics

Posted on 4/24/2025

Deadline 5/15/25
Bristol Myers Squibb

Bristol Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Compensation Overview

$180.5k - $205.8k/yr

Senior

Company Historically Provides H1B Sponsorship

Princeton, NJ, USA + 1 more

More locations: Lawrence Township, NJ, USA

May work remotely five (5) days every two (2) weeks within normal commuting distance of Lawrenceville, NJ.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Management
SQL
Tableau
Data Analysis
Requirements
  • Master’s degree or foreign equivalent degree in Information Technology and Management, or a related field
  • Two (2) years of post-baccalaureate experience
  • Experience with Statistics, Data Visualization, Tableau, and SQL
Responsibilities
  • Partner with global Field Medical teams and Business Insights & Analytics Therapeutic Leads to plan and provide data analytics and reporting support
  • Collaborate with Medical Analytics and the Field Strategy & Analytics teams to plan end to end delivery of projects
  • Manage offshore team members to drive continued execution of the Book of Work
  • Track and manage progress towards execution of therapeutic specific analytics book of work
  • Set up governance models to inform relevant stakeholders regarding the progress on the Book of Work
  • Communicate the results of the requested data analytics/insights with relevant stakeholders
  • Develop scorecards and ad-hoc analyses to monitor Field Medical execution for all key Medical events
  • Support ad-hoc analyses for more advanced data insights
  • Partner with cross functional Business Insights & Analytics, Information Technology, and Medical matrix colleagues to ensure necessary infrastructure and capabilities

Bristol Myers Squibb (BMS) develops and delivers medicines for serious diseases, focusing on oncology, immunology, and cardiovascular conditions. The company invests heavily in research and development to create new drugs, which are sold to hospitals and patients after receiving regulatory approval. BMS also produces affordable generic drugs and supports the development of biosimilars, ensuring access to quality healthcare. Their goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's $40B US investment signals strong commitment to growth despite cost-cutting.
  • AI partnership with Optellum enhances early lung cancer diagnosis and precision care.
  • Expansion in Gulf region under new leadership boosts market presence and opportunities.

What critics are saying

  • Layoffs and facility closures may disrupt production and market demand fulfillment.
  • New leadership appointments could shift company policy, impacting ongoing projects.
  • Acquisition of 2seventy bio may pose integration challenges affecting operational efficiency.

What makes Bristol Myers Squibb unique

  • BMS focuses on oncology, immunology, and cardiovascular diseases, setting it apart in biopharma.
  • The company invests heavily in R&D to develop innovative and generic medicines.
  • BMS emphasizes sustainability and ESG goals, enhancing its corporate responsibility image.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Company News

BioSpace
May 6th, 2025
BMS Pledges $40B Investment in US Despite Cost-Cutting Plans

This year alone BMS has laid off more than 800 employees, the bulk of which were just revealed this month, putting 516 jobs on the chopping block.

ROI-NJ
May 6th, 2025
Bristol Myers Squibb Names Gallman Executive Vp, General Counsel And Chief Policy Officer

Bristol Myers Squibb, the fourth-largest company in New Jersey by market cap, announced Tuesday the appointment of Cari Gallman as executive vice president, general counsel and chief policy officer, effective immediately. She succeeds Sandra (Sandy) Leung, who is retiring after a 33-year career at the company.Gallman has extensive experience in pharmaceutical law and compliance. She will lead the law department, which includes intellectual property, commercial and regulatory law, litigation, securities and corporate governance, transactions, corporate security and compliance and ethics, as well as global and U.S. policy and government affairs. Gallman has held leadership positions at Bristol Myers Squibb for 10 years, most recently serving as executive vice president, corporate affairs.“I am committed to continuing to build on the company’s culture of integrity and shape a dynamic policy environment that protects innovation and patients,” said Gallman in a statement.Gallman began her legal career in private practice representing pharmaceutical and medical device manufacturers in civil, regulatory, and government enforcement matters.She earned a bachelor’s degree in political theory from Princeton University, magna cum laude, and holds a juris doctor degree from Harvard Law School

Endpoints News
May 5th, 2025
Bristol Myers to lay off over 500 workers in New Jersey

Bristol Myers to lay off over 500 workers in New Jersey.

NJBIZ
May 5th, 2025
Bristol Myers Squibb plans 500+ layoffs in NJ

BMS recently announced plans to close a manufacturing facility in Illinois that handles viral vector production.

All Blog Things
May 3rd, 2025
BMS to lay off 516 employees at its Lawrence Township facility

BMS to lay off 516 employees at its Lawrence Township facility.

INACTIVE